This section is prepared for health professionals only
Pharmaceutical Form
Strengths
Area of Use
Tablet
100 mg
Excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD)
Pharmaceutical Form
Strengths
Area of Use
Tablet
200 mg
Excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD)
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
10 mg
Dementia associated with Alzheimer's disease
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
5 mg
Dementia associated with Alzheimer's disease
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
10 mg/20 mg
Dementia associated with Alzheimer's disease
Pharmaceutical Form
Strengths
Area of Use
Starter Pack/Tablet
10 mg/5 mg
10 mg/10 mg
10 mg/15 mg
10 mg/20 mg
Dementia associated with Alzheimer's disease
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
10 mg
Dementia associated with Alzheimer's disease
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
20 mg
Dementia associated with Alzheimer's disease
Pharmaceutical Form
Strengths
Area of Use
Oral solution
5 mg/puff
Dementia associated with Alzheimer's disease
Pharmaceutical Form
Strengths
Area of Use
Starter Pack/Tablet
5 mg+10 mg+15 mg+20 mg
Dementia associated with Alzheimer's disease
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
100 mg
Epilepsy
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
150 mg
Epilepsy
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
200 mg
Epilepsy
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
50 mg
Epilepsy
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
1000 mg
Epilepsy
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
250 mg
Epilepsy
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
500 mg
Epilepsy
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
750 mg
Epilepsy
Pharmaceutical Form
Strengths
Area of Use
Oral solution
100 mg/ml
Epilepsy
Pharmaceutical Form
Strengths
Area of Use
Oral suspension
1 mg/1 ml
Schizophrenia and bipolar disorder
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
100 mg
Schizophrenia and bipolar disorder
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
200 mg
Schizophrenia and bipolar disorder
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
25 mg
Schizophrenia and bipolar disorder
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
300 mg
Schizophrenia and bipolar disorder
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
400 mg
Schizophrenia and bipolar disorder
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
50 mg
Schizophrenia and bipolar disorder
Pharmaceutical Form
Strengths
Area of Use
Capsule
30 mg
Depression, general anxiety disorder and diabetic peripheral neuropathic pain
Pharmaceutical Form
Strengths
Area of Use
Capsule
60 mg
Depression, general anxiety disorder and diabetic peripheral neuropathic pain
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
10 mg
Major depressive episodes, panic disorder, social phobia, generalised anxiety disorder and obsessive-compulsive disorder
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
15 mg
Major depressive episodes, panic disorder, social phobia, generalised anxiety disorder and obsessive-compulsive disorder
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
20 mg
Major depressive episodes, panic disorder, social phobia, generalised anxiety disorder and obsessive-compulsive disorder
Pharmaceutical Form
Strengths
Area of Use
Film-coated tablet
5 mg
Major depressive episodes, panic disorder, social phobia, generalised anxiety disorder and obsessive-compulsive disorder
Pharmaceutical Form
Strengths
Area of Use
Tablet
1 mg
Parkinson's disease